Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Retention in Vedolizumab-treated Patients With Active UC After the Addition of Adjunct CurQD: A Retrospective Cohort Study

NCT07240168 is registered in ClinicalTrials.gov with Evinature Ltd. as lead sponsor.

NCT NCT07240168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07240168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Retention in Vedolizumab-treated Patients With Active UC After the Addition of Adjunct CurQD: A Retrospective Cohort Study
Lead sponsor
Evinature Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
September 7, 2025
Completion date
August 20, 2026
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)